Submitted by Anonymous (not verified) on 19 October 2023 - 10:20
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, COVID-19 virus infection, Date of authorisation: 28/01/2022, Revision: 14, Status: Authorised
Source: